Are ketogenic diets promising for Alzheimer's disease? A translational review

被引:47
|
作者
Lilamand, Matthieu [1 ,2 ,3 ,4 ]
Porte, Baptiste [1 ,2 ]
Cognat, Emmanuel [1 ,2 ]
Hugon, Jacques [1 ,2 ]
Mouton-Liger, Francois [1 ,2 ]
Paquet, Claire [1 ,2 ]
机构
[1] Univ Paris, INSERM, U1144, Optimisat Therapeut Neuropsychopharmacol, Paris, France
[2] Nord Univ Paris, Lariboisiere Hosp, APHP, CMRR Paris Nord Ile France,Ctr Neurol Cognit, 200 Rue Faubourg, F-75010 Paris, France
[3] APHP Nord Univ Paris, Dept Geriatr, Bichat, Bretonneau Hospitals, F-75018 Paris, France
[4] Nord Univ Paris, Bichat & Bretonneau Hosp, APHP, Dept Geriatr, F-75018 Paris, France
关键词
Ketogenic diet; Alzheimer's disease; Brain metabolism; Animal models; MOUSE MODEL; COGNITIVE IMPAIRMENT; BETA-HYDROXYBUTYRATE; KETONE ESTER; SUPPLEMENTATION; METABOLISM; MITOCHONDRIA; MEMORY;
D O I
10.1186/s13195-020-00615-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Brain amyloid deposition and neurofibrillary tangles in Alzheimer's disease (AD) are associated with complex neuroinflammatory reactions such as microglial activation and cytokine production. Glucose metabolism is closely related to neuroinflammation. Ketogenic diets (KDs) include a high amount of fat, low carbohydrate and medium-chain triglyceride (MCT) intake. KDs lead to the production of ketone bodies to fuel the brain, in the absence of glucose. These nutritional interventions are validated treatments of pharmacoresistant epilepsy, consequently leading to a better intellectual development in epileptic children. In neurodegenerative diseases and cognitive decline, potential benefits of KD were previously pointed out, but the published evidence remains scarce. The main objective of this review was to critically examine the evidence regarding KD or MCT intake effects both in AD and ageing animal models and in humans. Main body We conducted a review based on a systematic search of interventional trials published from January 2000 to March 2019 found on MEDLINE and Cochrane databases. Overall, 11 animal and 11 human studies were included in the present review. In preclinical studies, this review revealed an improvement of cognition and motor function in AD mouse model and ageing animals. However, the KD and ketone supplementation were also associated with significant weight loss. In human studies, most of the published articles showed a significant improvement of cognitive outcomes (global cognition, memory and executive functions) with ketone supplementation or KD, regardless of the severity of cognitive impairments previously detected. Both interventions seemed acceptable and efficient to achieve ketosis. Conclusion The KD or MCT intake might be promising ways to alter cognitive symptoms in AD, especially at the prodromal stage of the disease. The need for efficient disease-modifying strategies suggests to pursue further KD interventional studies to assess the efficacy, the adherence to this diet and the potential adverse effects of these nutritional approaches.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Editorial: Progress of Translational Medicine in Alzheimer's Disease
    Zhang, Can
    Fang, Evandro Fei
    Wang, Changning
    FRONTIERS IN AGING NEUROSCIENCE, 2022, 14
  • [42] Alzheimer's disease and immune activation:: A translational perspective
    Bossù, P
    Ciaramella, A
    Moro, ML
    Spalletta, G
    Caltagirone, C
    NEUROSCIENCE RESEARCH COMMUNICATIONS, 2004, 35 (03) : 193 - 201
  • [43] Translational research for therapeutic strategy of Alzheimer's disease
    Takata, Kazuyuki
    Kitamura, Yoshihisa
    Shimohama, Shun
    Ashihara, Eishi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2013, 121 : 42P - 42P
  • [44] Translational approaches to understanding resilience to Alzheimer's disease
    Neuner, Sarah M.
    Telpoukhovskaia, Maria
    Menon, Vilas
    O'Connell, Kristen M. S.
    Hohman, Timothy J.
    Kaczorowski, Catherine C.
    TRENDS IN NEUROSCIENCES, 2022, 45 (05) : 369 - 383
  • [45] Translational proteomics in Alzheimer's disease and related disorders
    Ghidoni, Roberta
    Paterlini, Anna
    Benussi, Luisa
    CLINICAL BIOCHEMISTRY, 2013, 46 (06) : 480 - 486
  • [46] The ketogenic diet as a potential treatment and prevention strategy for Alzheimer's disease
    Broom, Gina M.
    Shaw, Ian C.
    Rucklidge, Julia J.
    NUTRITION, 2019, 60 : 118 - 121
  • [47] Randomized crossover trial of a modified ketogenic diet in Alzheimer's disease
    Phillips, Matthew C. L.
    Deprez, Laura M.
    Mortimer, Grace M. N.
    Murtagh, Deborah K. J.
    McCoy, Stacey
    Mylchreest, Ruth
    Gilbertson, Linda J.
    Clark, Karen M.
    Simpson, Patricia, V
    McManus, Eileen J.
    Oh, Jee-Eun
    Yadavaraj, Satish
    King, Vanessa M.
    Pillai, Avinesh
    Romero-Ferrando, Beatriz
    Brinkhuis, Martijn
    Copeland, Bronwyn M.
    Samad, Shah
    Liao, Shenyang
    Schepel, Jan A. C.
    ALZHEIMERS RESEARCH & THERAPY, 2021, 13 (01)
  • [48] Randomized crossover trial of a modified ketogenic diet in Alzheimer’s disease
    Matthew C. L. Phillips
    Laura M. Deprez
    Grace M. N. Mortimer
    Deborah K. J. Murtagh
    Stacey McCoy
    Ruth Mylchreest
    Linda J. Gilbertson
    Karen M. Clark
    Patricia V. Simpson
    Eileen J. McManus
    Jee-Eun Oh
    Satish Yadavaraj
    Vanessa M. King
    Avinesh Pillai
    Beatriz Romero-Ferrando
    Martijn Brinkhuis
    Bronwyn M. Copeland
    Shah Samad
    Shenyang Liao
    Jan A. C. Schepel
    Alzheimer's Research & Therapy, 13
  • [49] Organic Foods in Diets of Patients with Alzheimer's Disease
    Dziuba, Szymon
    Cierniak-Emerych, Anna
    Klimova, Blanka
    Poulova, Petra
    Napora, Piotr
    Szromba, Sylwia
    SUSTAINABILITY, 2020, 12 (04)
  • [50] Promising Natural Remedies for Alzheimer's Disease Therapy
    Thawabteh, Amin Mahmood
    Ghanem, Aseel Wasel
    Abumadi, Sara
    Thaher, Dania
    Jaghama, Weam
    Karaman, Donia
    Karaman, Rafik
    MOLECULES, 2025, 30 (04):